Roivant Sciences Ltd. SEC filings ROIV

Roivant Sciences Ltd. has 995 filings in SEC EDGAR's recent list, going back to Mar 16, 2015. Its latest annual report, Form ARS, was filed on Jul 29, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (regulation fd disclosure). The company's fiscal year ends on March 31.

Form Description Filed Period
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
10-Q Quarterly report Feb 6, 2026 Dec 31, 2025
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
10-Q Quarterly report Feb 10, 2025 Dec 31, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
10-Q Quarterly report Feb 13, 2024 Dec 31, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
10-Q Quarterly report Feb 13, 2023 Dec 31, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
10-Q Quarterly report Feb 14, 2022 Dec 31, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
10-Q Quarterly report Sep 21, 2021 Jun 30, 2021

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ROIV (Nasdaq)
Fiscal year ends
March 31
Incorporated in
Bermuda
Headquarters
London
SEC filer status
Large accelerated filer
SEC CIK
1635088

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.